DERM Journey Medical Corporation

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · journeymedicalcorp.com

5.950USD-3.41%Mkt Cap: 167.94M $P/E: —1d ago

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$58.68BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.43BUSDP/E 112.9

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.17BUSD

RDY

Dr. Reddy's Laboratories Limited

Hims & Hers Health, Inc.

$6.89BUSD

AMRX

Amneal Pharmaceuticals, Inc.

$6.84BUSDP/E 40.1

Key Statistics

Company

Market Cap167.94M USD

Enterprise Value173.76M USD

Revenue (TTM)68.18M USD

Gross Profit40.93M USD

Net Income (TTM)-11.43M USD

Revenue/Share2.55 USD

Last Price5.950 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees58

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-102.67

PEG—

EV/EBITDA142.90

EV/Revenue2.55

P/S2.55

P/B5.31

EPS (TTM)-0.22

EPS (Forward)-0.06

52W Range

4.31031% of range9.555

52W High9.555 USD

52W Low4.310 USD

Profitability

Gross Margin66.17%

Oper. Margin2.46%

EBITDA Margin1.78%

Profit Margin-18.48%

ROE-35.89%

ROA-12.08%

Growth

Revenue Growth23.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-12.44M USD

CapEx (TTM)—

FCF Margin-8.01%

FCF Yield-3.25%

Net Debt-102.00K USD

Net Debt/EBITDA-0.08

Balance Sheet

Debt/Equity0.80

Current Ratio1.59

Quick Ratio1.35

Book Value/Sh1.16 USD

Cash/Share0.91 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)13.75 USD

Upside (mean)+131.1%

Target Range13.00 USD – 15.00 USD

13.00+131.1% to mean15.00

# Analysts4

Ownership

Shares Out.22.22M

Float15.59M

Insiders31.75%

Institutions49.77%

Short Interest

Short Ratio19.2d

Short % Float18.47%

Short % Out.10.37%

Shares Short2.93M

Short (prev mo.)2.92M

Technical

SMA 506.950 (-14.4%)

SMA 2006.861 (-13.3%)

Beta1.11

S&P 52W Chg16.45%

Avg Vol (30d)176.72K

Avg Vol (10d)187.76K

Technical Indicators

RSI (14)35.9

MACD-0.2207

MACD Signal-0.1313

MACD Hist.-0.0894

BB Upper7.905 USD

BB Middle6.844 USD

BB Lower5.783 USD

BB Width31.01%

ATR (14)0.3925 USD

Vol Ratio (20d)1.12x